DEVACELL

devacell-logo

DevaCell is a transformative biopharmaceutical company focused on the development of high impact, synthetic vector-based therapeutics that offer the potential to revolutionize patient care and improve outcomes for patients across a wide range of therapeutic indications.

#SimilarOrganizations #Website #More

DEVACELL

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical Therapeutics

Founded:
2015-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.devacell.com

Total Employee:
1+

Status:
Active

Contact:
+1 858 481 1120

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Domain Not Resolving Wordpress Plugins COVID-19 GoDaddy SSL


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

pana-bio-logo

Pana Bio

Pana Bio is a biotechnology company that delivers therapeutic molecules in vivo.

zyagen-logo

Zyagen

Zyagen is a biotechnology firm that provides life science products and services with focus on gene expression since 2000.

Official Site Inspections

http://www.devacell.com

  • Host name: cloudproxy10004.sucuri.net
  • IP address: 192.124.249.4
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "DevaCell"

DevaCell - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +1 858 481 1120 DevaCell is a transformative biopharmaceutical company focused on the development of high impact, synthetic vector-based therapeutics that offer the potential to …See details»

About - DevaCell

Recognizing the significant, unmet medical need, DevaCell’s mission is driven by an urgency to discover, develop and bring game changing new therapeutics to patients in need. This mission …See details»

DevaCell – Designer Encapsulated Vector Assembly

DevaCell’s ONCoatâ„¢ synthetic vector-based platform technology is enabling transformative, new therapeutic opportunities across three key segments: Oncolytic virus therapy, vaccines and gene therapy/gene editing application. …See details»

DEVACELL, INC. Overview | SignalHire Company Profile

DEVACELL, INC. is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by David …See details»

DevaCell Company Profile | Management and Employees List

DevaCell's DEVA (designer encapsulated viral assembly) is the foundational innovation for the company's transformative nanoparticle-based, ONCoatTM sy nthetic vector platform …See details»

DevaCell Company Profile 2024: Valuation, Funding & Investors

DevaCell General Information Description. Developer of a novel enzyme nano-encapsulation technology intended to deliver viral doses to metastases. The company's technology …See details»

DevaCell, Inc. Company Profile | San Diego, CA | Competitors ...

Find company research, competitor information, contact details & financial data for DevaCell, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

DEVACELL, INC.: Contact Details and Business Profile

The DEVACELL, INC. annual revenue was $952000 in 2023. Who is the Co-founder, Chief Scientific Officer of DEVACELL, INC.? Inanc Ortac is the Co-founder, Chief Scientific Officer of …See details»

DevaCell - Products, Competitors, Financials, Employees, …

DevaCell specializes in synthetic vector-based platform technology within the biotechnology sector, focusing on oncological and gene therapy applications. The company's main offerings …See details»

DEVACELL, INC. - VentureRadar

DevaCell is a preclinical stage therapeutics company developing next generation viral therapeutics with programs in vaccines, oncolytic virotherapy and gene therapy. Vaccine:Our …See details»

DevaCell - Overview, News & Similar companies | ZoomInfo.com

Jan 5, 2021 Who is DevaCell. DevaCell is a San Diego based synthetic vector-based therapeutics firm focused on developing a product pipeline of best-in-class therapeutics acros …See details»

DevaCell Company Profile - Office Locations, Competitors ... - Craft

DevaCell is a biotechnology company. It develops a nanoencapsulation and virus coating technology that generates a nanolayer around a virus surface without harming the virus or …See details»

Investors & Media - DevaCell

DevaCell is a preclinical-stage biopharmaceutical company focused on developing next-generation synthetic vector-based immunotherapies based on the ONCoatâ„¢ synthetic vector …See details»

DevaCell - Contacts, Employees, Board Members, Advisors & Alumni

DevaCell is a biotechnology firm that offers therapeutic indications.See details»

DevaCell - Updates, News, Events, Signals & Triggers - Crunchbase

Organization. DevaCell . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Research and Development Insight Details. Powered by AI . Edit …See details»

Devacell, Inc. | Nanotechnology Company | NPD

DevaCell is rapidly advancing a pipeline of therapeutic product candidates based on a proprietary synthetic vector engineering platform technology. Key therapeutic segments include - oncolytic …See details»

DevaCell - BIO Investor Forum | BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... DevaCell is developing …See details»

Our Technology - DevaCell

ONCoatâ„¢ DevaCell is developing next-generation, engineered, synthetic vector based therapeutics based on the company’s ONCoatâ„¢ synthetic vector platform technology, …See details»

DEVACELL, INC. - VentureRadar

DevaCell is a preclinical stage therapeutics company developing next generation viral therapeutics with programs in vaccines, oncolytic virotherapy and gene therapy. Vaccine:Our …See details»

Oncology – DevaCell

DevaCell’s synthetic vector includes an engineered adenovirus subtype 5 (Ad5). After invading cancer cells, the virus replicates and following multiple cycles of viral replication, the cancer …See details»

linkstock.net © 2022. All rights reserved